Daniel K. Spiegelman, EVP, Chief Financial Officer at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 10,000 shares at $99.00 ($990K) on 2018-06-22, disclosed to the SEC on 2018-06-26.
Seasonal sale ($990k) by EVP, Chief Financial Officer — this insider has traded BMRN in June in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $99.00 | 9,528 | $943K | 95.3% |
| 2 | $99.01 | 472 | $47K | 4.7% |
| Total | $99.00 avg | 10,000 | $990K | 100% |
| Filing → |
| MYGN | SELL | 2022-06-06 | $124K | — | Filing → |
| MYGN | SELL | 2021-06-17 | $192K | — | Filing → |
| MYGN | SELL | 2021-06-01 | $414K | — | Filing → |